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Abstract: The COST CARES project aims to support healthcare cost containment and improve
healthcare quality across Europe by developing the research and development necessary for
person-centred care (PCC) and health promotion. This paper presents an overview evaluation
strategy for testing ‘Exploratory Health Laboratories’ to deliver these aims. Our strategy is theory
driven and evidence based, and developed through a multi-disciplinary and European-wide team.
Specifically, we define the key approach and essential criteria necessary to evaluate initial testing, and
on-going large-scale implementation with a core set of accompanying methods (metrics, models, and
measurements). This paper also outlines the enabling mechanisms that support the development of
the “Health Labs” towards innovative models of ethically grounded and evidenced-based PCC.
Keywords: We-CARE; person-centred care; patient-centred care; person-centred care; person centred
care; evaluation; complex intervention; quality of care; cost containment; ethically grounded;
evidence-based model
1. Introduction
The World Health Organisation defines Universal Health Care as that ‘which all citizens can access
without incurring financial hardship’ [1]. Many nations fail to provide this as a basic human right,
Int. J. Environ. Res. Public Health 2020, 17, 3050; doi:10.3390/ijerph17093050 www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2020, 17, 3050 2 of 19
with half of the global population failing to access fundamental healthcare, and around 100 million
people experiencing extreme hardship as a consequence of healthcare costs [2]. This is particularly true
of nations with large income disparities and those without centrally funded health systems. In Europe
and the UK, the situation is less stark, but the rising costs of healthcare are a threat to this basic tenet of
post-war health policy [3–5].
Cost containment/saving initiatives in healthcare have been a consistent feature of health policy
across Europe since the global economic crisis [6–10]. In the UK and Europe, a multitude of health
policies have called for more efficiency and less waste [11], better integration of healthcare practices and
services [12,13], the adoption of techniques of ‘lean’ management in the public sector similar to the ones
utilized in the private sector [14,15], and, in some cases, privatization and competition [16]. Such policy
drivers have also been in response to the changing nature of medicine and public health [14,15].
In some regions, people are living longer albeit more incapacitated lives, whilst in other regions,
child mortality and early preventable death result from poverty and a marked social gradient of
health [17,18]. Underlying these issues is the reality of healthcare spending, which is continuing to
rise year after year as a growing percentage of GDP [19]. With EU healthcare spending estimated at
€1.457 billion per year, saving just 1% could result in a saving of € 14.6 billion [20]. Healthcare, thus,
holds great potential for cost containment.
The WE-CARE project (Grant Agreement 602131) was funded between September 2013 and
August 2015 under the EU’s Seventh Framework Programme for Research (FP7). The project and
its consortium were convened to tackle cost containment and quality care in recognition of the role
these play in ensuring the accessibility and affordability of future health care for EU citizens. A key
output—the WE-CARE Roadmap [21]—proposed seven interdependent themes to facilitate this aim.
These themes consisted of: (1) Core drivers: Person-Centred care (PCC) and Health Promotion (HP);
and (2) five critical enablers for their implementation: technology, quality measures, infrastructure,
incentive systems, and contracting strategies.
Complex interventions that address cost containment and the quality of care through core drivers
of PCC and HP are likely to require at least some critical enablers for successful implementation. These
interventions will also require commitment from a range of key stakeholders, who must come together
to find ethical and sustainable solutions [22]. A shift in thinking to one based on ‘collaborative action
(CA)’ [23], which will include people, communities, health and social care providers, government at
various levels, and a range of Non-Government Organisations (NGOs), is thus essential to establish
these interventions. Guided by this approach, innovative models are required across Europe to
prototype healthcare based on HP and PCC, emphasizing preventive self-assessment above reactive
expert care. Such models must learn from each other and share some common elements, but may differ
in geographical and health care system characteristics. Financed through different sources (e.g., EU
funding for evaluation, government funding for implementation) their benefits may stretch far beyond
the initial test beds.
1.1. Why Person-Centred Care (PCC) and Health Promotion (HP)?
PCC and HP are synergistic and a vital part of modern and ethical health care. A growing evidence
base suggests that these core approaches can improve health outcomes [24], maintaining health care
quality without increasing costs [25,26].
‘Person-centred care’, rather than ‘patient-centred care’, is emphasized because the word ‘patient’
is associated with a passivity in medical encounters [21,26]. For example, patients often adapt to
the professional norms of healthcare organizations, rather than receiving care focused on their own
resources and needs, preferences, and values [27]. Our notion of PCC is underpinned by the ethics of
personhood and the capability approach [28]. The term ‘patient’ therefore is not commensurate with
the person as an active partner in care and co-creator of their care [21,26]. Indeed, these two roles of
the patient as a ‘person’ accurately describe the radical paradigm shift from patient- to person-centred
healthcare that is necessary to reflect the philosophical and ethical changes in the delivery of PCC.
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Health Promotion as an approach aims to inform, influence, and support people, communities,
and organisations to improve health. Supporting people to increase control over their health is in
essence health promoting, both for the individual and society [29,30]. HP activities can work in
synchronicity with PCC if developed in partnership with the person, taking into consideration their
life context and socioeconomic conditions [31,32].
1.2. Testing the Roadmap: A European Network for Cost Containment and Improved Quality of Health Care
COST Action 15222 ‘Cost Cares’ was funded by the EU Commission to create the impetus in both
the research and development required to design and test innovative exploratory health laboratories
(EHLs) to implement PCC and HP across the EU. This paper sets out a strategy for evaluating them.
2. Methods
Defining and Understanding the Role of Critical Enablers
To understand how the EHLs might work to deliver PCC, HP, and cost outcomes, it was first
necessary to develop Programme Theories (PTs). PTs describe how interventions (service, treatment,
policy) are thought to work by specifying the ways in which they produce outcomes. They are a set of
causal relationships often referred to as “If-Then” statements. They can also be written or represented
graphically to show the relationships between cause and effect. PTs are also useful for understanding
both the positive and negative impacts that can occur when interventions are implemented. They are
often accompanied by logic models, which help plan and evaluate interventions based on their
internal logic, and the role of context in supporting successful delivery and evidence acquisition.
We created evidenced-based PTs to specify how EHLs would deliver PCC, HP, and cost outcomes
through the critical enablers detailed in the We-CARE Roadmap (see Figure 1). Repeated here for
clarity the critical enablers are (1) information technology (IT), which describes the use of computers or
other computerized devises to store, transmit, and receive data to support PCC planning and care
coordination, for handling and communicating health and evaluation data, and for delivering PCC
and HP interventions. (2) Quality measures, such as organizational processes, that ensure health
services increase the likelihood of the desired health outcomes consistent with current scientific
knowledge, which take into consideration an individual’s preferences, and ensure that health services
are effective, affordable and accessible to all citizens. (3) Infrastructure to create the necessary resources
and structures that support the shift from health systems that are excessively hospital-centric and
biomedically-oriented, to those which value continuity, responsiveness, and multidimensionality
in community care, e.g., shifts in staffing, training, and delivery of care. (4) Incentive systems that
reward PCC processes and outcomes, such as personal health goals, PCC plans, improvements in
patient self-efficacy and experiences of care, and HP activities. This will require an expansion and
critical revision of existing system-based biomedically driven performance indicators. (5) Contracting
strategies that define and endorse PCC incentive systems and infrastructural support and efficiencies
for EHLs, purchasing strategies and contracts between payers and providers of healthcare that promote
the alignment in organisational goals based on PCC, HP, and cost containment. (6) Cultural change that
represents shared assumptions, values, and beliefs that govern how people behave in an organisation.
Receptiveness or readiness to change is considered a prerequisite for EHLs. As other critical enablers
are modified within a given EHL, cultural change towards PCC, HP, and cost containment may present
as either a pre-requisite and/or a natural consequence of development. The addition of this sixth critical
enabler represents the importance of organizational culture in achieving PCC and cost stability.
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Figure 1. The intersections of critical enablers and the core process of person-centred care and
health promotion.
Upon establishing agreed definitions of the above enablers, the next step was to hypothesize how
these might work to support the aims of an EHL. Following this step, the literature was searched to
detect evidence for the hypothesized statements, referred to as ‘if-then’ statements. To expedite this
process, tables of ‘if-then’ statements were compiled, which, in keeping with the evaluation methods
of critical realism [33,34], permitted the compilation of patterns of causal chains within the EHL.
For example, IF condition X is in place (e.g., practitioners are incentivized to engage in shared decision
making with patients), THEN outcome Y might follow (e.g., patients will feel like they are taking an
active role in rehabilitation planning), thus improving service user experiences of PCC [35]. This task
facilitated exploration of how the critical enablers interacted with PCC and HP to improve quality PCC
and cost containment (see Figure 1). The points at which PCC and HP intersect with each of the critical
enablers in Figure 1 are referred to as intersection points (e.g., PCC and information technology (IT)).
3. Evaluation Strategy
This section describes the considerations and necessary steps for evaluating and implementing
EHLs to improve quality PCC and cost containment. First, the practice of PCC is explored, and
then the role of critical enablers is illustrated. A number of controlled studies have been performed
comparing PCC to usual care [21,36–38]. The core components in the interventions have been to listen
carefully to the patient’s illness narrative and to mutually agree on a health plan. The true case story
(see Figure 2) previously published in a position paper demonstrates how the patient narrative can
open up and reveal information needed for the patient and the professionals to be able to agree on a
relevant health plan [39]. This is concordant with the theory and philosophy that PCC is based on
starting with each person’s capability and wish to take responsibility for their own health. The true
case below is a vignette based on a real person to illustrate how PCC can be applied in practice through
a worked example.









‘Mr. G is a 72 year old retired man and avid golfer who had had a small myocardial infarction 15 
years ago. After recovery from the infarction he returned to playing golf and was in good health 
until one day he suddenly collapsed. Resuscitation was immediately initiated. An ambulance 
arrived shortly afterwards and he was defibrillated. A myocardial infarction was later diagnosed 
at a local hospital. He recovered well, while a cardiac dysfunction was diagnosed and he was 
prescribed medicines (ACE-inhibitor and a betablocker). He was referred to a tertiary hospital 
for an Implantable Cardiac Defibrillator (ICD); however, a new angiography of his coronary 
lesion indicated the need for a coronary by-pass operation. The operation was scheduled to be 
performed a few months later.’  
 
Initiating the narrative 
Sometime after being informed about the operation, Mr. G met with his district nurse and general 
practitioner Dr. S for a yearly check-up. Mr. G explained that he did not feel well and was very 
worried about the upcoming surgery. He was so concerned about his condition that he did not 
dare to walk any distances and had given up golf. However, from the illness narrative it was clear 
that Mr. G had no symptoms such as dyspnea or chest pain. When Mr. G was asked what he 
wanted to do, he became surprised, saying that none of his doctors had once asked him that 
question. Instead, they had simply informed him that he was to be operated on and he assumed 
that he had no other option. However, he said that he would prefer not to go through with the 
operation. 
 
Formulating a health plan together 
Mr. G was asked if he would mind if Dr. S and the care team took a closer look at his case. After 
reviewing Mr. G's records, Dr. S concluded that his condition did not clearly indicate by-pass 
surgery and that pharmacological treatment was a viable option. None of the records made any 
reference to Mr. G's concerns about surgery or his preferences for treatment. Asked if he still 
preferred not to have surgery and instead continue with his medication, as this was what the 
guideline recommended, Mr. G answered that he did and that his wife supported him in this 
decision. 
 
Documenting PCC and health promotion 
Mr. G expressed some concern about what his physicians at the tertiary hospital would say if he 
now declined the operation. Dr. S assured him that he would inform the physicians about their 
discussion and that Mr. G's decision about and preference for treatment would be documented in 
his patient record and that future options, e.g. an operation, would still be valid. After this talk, 
Mr. G became markedly relieved. During the seven years since that time Mr. G has continued with 
pharmacological treatment and has felt well and enjoyed an active life without any cardiac-
related symptoms. 
Figure 2. The illness story of Mr. G.
3.1. The Illness Story of Mr. G: An Example of the Enablers of PCC and HP
PCC for Mr. G was facilitated via various critical enablers, detailed in the following:
Information technology: The medical documentation and information (in the patient records) as
well as the commonly formulated treatment and health plan are digitalized and accessible to Mr. G
and his providers in a way that he comprehends and can agree or ask questions about. In formulating
the health plan, Mr. G was supported by a digital patient decision aid [40]. Health information
technology (IT) systems support the smooth flow of information between services, and to and from
citizens and their families. Artificial intelligence might facilitate this and help improve interactions
with patients [41]. Quality measures: Mr. G was invited to download an app after his first myocardial
infarction where he can follow the development of symptoms and well-being and contact health
care services for help and support with formulating his personal health plan. Contracting strategies,
incentives, and infrastructure: The infrastructure supported cumulative documentation according to
the criteria for PCC. This was linked to incentive payments for the whole team. This type of incentive
payment includes quality measures (care plans) that are sanctioned and contracted between the
provider and commissioner organisation.
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3.2. Causal Relationships between Enablers, Outcomes, and Measurement
Program theories (PTs) are useful ways in which to facilitate an understanding of how complex
interventions work; in this case, how the critical enablers could work with PCC and HP interventions
to generate cost containment and quality PCC outcomes. Table 1 provides 11 worked examples of PTs
referred to as ‘if-then’ statements with explanatory ‘because’ statements and associated suggestions for
assessment or measurement. Instruments and methods to assess PTs should be carefully selected and
the use of mixed methods is advised. Knowledge base and practical constraints will add to the existing
complexity of measurement and evaluation. The type of design employed can help remedy some of
these issues. For example, beginning with small-scale and qualitative assessment will help determine
what to measure and how to measure it, and what improvements to expect. Ensuring measures or
assessments capture professional and patient partnership work in care planning is key for emphasizing
the importance of this for PCC.
The following PTs are presented here as examples of a larger body of work (available from the
first author) conducted to inform the design and evaluation of EHLs. Table 1 presents seven different
types (A–G) of evidence-based PTs that could shape the design of an EHL.
Type A (contracting strategies for quality and cost outcomes) PTs represent how contracting
strategies could operate at macro and meso levels to support quality PCC and contain cost. In the
two examples provided, ‘alliance’ or ‘partnership’ models contract to deliver an EHL based on shared
or co-designed PCC and HP objectives to improve quality PCC and costs. This fosters trust and
productivity based on collective ownership and the sharing of risk and reward within EHL. A mixture
of quantitative and qualitative measures of delivery and management team dynamics, and progress
towards aligned goals (e.g., PCC health plans), and costs over time could be used to ascertain the
success of the contracting strategy. These enablers provide causal mechanisms for cost and quality
outcomes at macro and meso levels within the EHL.
Type B (incentives and contracting strategies for quality PCC resulting in cultural change) PTs
represent the potential for contracting strategies combined with incentives to improve cost and quality
outcomes by providing incentives at multiple levels across the EHL. For example, if cost effectiveness
is measured across the whole care chain with the savings provided to all participants, this creates
the potential to act as an incentive towards aligned PCC and cost goals. To combat perceptions of
unfairness in the equal distribution of savings across the system, objective measures of effort will
need to be employed. These measures, however, should to be balanced against the knowledge of the
operational context. For example, settings low on staff resources may seem to have contributed less
towards the achievement of savings across the chain. Ensuring that contextual knowledge supports
objective measurement will help communicate the conditions of contributors towards the savings
gained and shared. Long-term planning and monitoring, active communication, and shared goals
will help mitigate against perceptions of unfairness. Redistributing resources based on savings can
help achieve the stated organization goals and thus improve the sector’s efforts where these are
perceived to be lacking. These seemingly radical shifts align to the principles of fair division and
social choice [59]. Over time, resultant cultural change across the system could be operationalized
as permanent transformation of routines/habits. Measures of PCC and HP routines/habits, savings
distribution, and measures of patient experience of care could help establish if this strategy is beneficial.
Type C (contracting strategies, incentives, and quality measures for cost and quality) PTs combine
contracting strategies with incentives and quality measures to effect change in quality and costs. These
build on type A and B PTs by, for example, suggesting that if contract payments are made at the
same time to all providers and tied to measures of PCC and HP, this fosters trust and productivity by
reducing the misalignment and unproductive competition between partners and reduces transaction
hazards operating at macro and meso levels within the system.
Type D (incentives for quality PCC) PTs work at the micro level with incentives applied equally
to all delivery staff irrespective of hierarchy or professional grouping [22,46] (e.g., patient feedback
forms at clinic and ward levels). For quality PCC outcomes to be achievable, incentives must ensure
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that the reward system motivates individuals to align their own goals with those of the organization
(EHL) [60,61]. As the PCC approach is based on qualitative changes, financial incentives may not be the
best type of incentive to test. It has been long recognized that financial incentives are positively related
to quantitative performance (e.g., number of tasks completed) but not necessarily with performance
quality [62–65]. Thus, ideally, particularly since PCC is based in an Aristotelian ethics of virtues, the
incentive systems should be a combination of financial and non-financial rewards (e.g., recognition,
positive feedback from leaders, promotions, money, as well as target setting and performance evaluation
itself) [66,67]. These rewards would be directed to all EHL members, since in “a complex network of
interdependent relationships” [68,69] necessary for PCC implementation, it is difficult to identify an
individual contribution. The success of micro-level incentives can be measured by carefully selected
patient experience measures and focus groups.
Type E (incentives, quality measures for cost, and quality PCC) PTs work by combining incentives
with quality measures at macro and meso levels. For example, if a PCC quality measure is linked
to an EHL accounting system and able to deliver cost containment information resulting from PCC
processes, then the measure itself becomes the incentive. Quality measures therefore act as both an
aligned incentive and measurement of implementation. A pre- and post-comparison of costs associated
with PCC quality processes analyzed against quality measure scores would provide an assessment of
effectiveness. A benchmarking strategy against non-EHL settings may be an example of a measurement
process being itself an incentive. It is important to note that the cost containment may not be immediate,
as some costs may be incurred upfront and/or it may take time for outcomes to stabilize or become
apparent. EHLs employing longitudinal designs can help to account for these potential delays.
Type F (Information Technology for quality) PTs provide examples of how IT has the potential
to improve quality. These PTs work to support patient self-management through mobile technology,
for example, through symptom monitoring or appointment reminders, to help people manage their
own health [52]. They may also operate to support the adoption of PCC electronic health records and
care plans, which provide teams with the tools to maintain and share PCC information. Measurement
and evaluation of these mechanisms would be tailored to detect changes in patient self-management
activities, team effectiveness, and resultant health system impact (e.g., reviews, appointments attended,
etc.). In the current COVID-19 context, remote monitoring of patients, video-linked consultations, and
e-health interventions could provide an exciting opportunity to test the delivery of person-centred care
remotely, with the potential to calculate costs compared to previous standard practice [70].
Type G (Infrastructure for quality PCC) PTs provide examples of how components of an
organization’s infrastructure could help result in quality care at meso and micro levels. At a meso
level, if staff training is provided to enhance professional skills to support patient empowerment and
enhance professional communication skills, this then has the potential to improve PCC delivery and
experience of care. Furthermore, using patient-reported measures to shape care planning and use of
the feedback from these measures to improve staff training has the potential to embed the patient
voice in quality improvement practices and shape equitable person-centred relationships between
professionals and patients [54]. A multitude of measures are available to measure these outcomes [27]
and for use in care planning in this way. However, sampling care plans with patient-reported outcome
measures (PROM) and interviews with professionals and patients would be insightful.
These examples of PTs are not comprehensive, but they illustrate how those developing EHLs can
use these and other mechanisms to design their interventions and corresponding evaluation strategies.
For further guidance on the use of evaluation metrics and measures, see p3c.org.uk.
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Table 1. Program theories, if-then-because statements, and measurement/assessment examples.
PT Type IF-THEN Because Measurement/Assessment
A
IF delivery organizations, owners,
financiers, and commissioners form an
‘Alliance’ contract to deliver the EHL
based on shared and co-designed PCC/HP
objectives, THEN the quality of PCC will
improve, and costs may stabilize [42–44]
a context of trust based on
the sharing of risk and




Delivery team dynamics and communication.
Aligned goals at macro, meso and micro
levels. Progress against goals, e.g., number of
PCC care plans with personal HP plan across
providers. Performance of each provider
towards the unified goal. Qualitative and
quantitative measures (e.g., P3C-EQ, PPE15,
P3C-OCT)
A
IF partnership models are created with
community NGOs with PCC and HP
agreed outcomes, THEN PCC, HP, and
Cost containment will improve [45]
of increased access to social
and HP activities, resulting
in less reliance on medicines
and treatments
Exploration of how outcomes were set, e.g.,
through stakeholder consultation, focus
groups and interviews. Number HP activities.
PCC processes. Patient experience of PCC
(P3C-EQ)
B
IF incentives are provided at multiple
levels, THEN this is more likely to lead to
increased PCC [46]
it contributes to cultural
change and the contingency
is in place at micro, meso,
and macro levels
Measure of cultural change (OR4KT) and
organizational readiness for change (e.g.,
P3C-OCT). Interviews with stakeholders
across levels
B
IF cost effectiveness of PCC and HP is
measured on the whole PCC chain and
savings divided between all participants,
THEN all stakeholders will benefit
egoistic behavior of
individuals in PCC delivery
and organizational chains
would be diminished
Comparative measurement of the cost of PCC
provision/savings to all participants; include
incentives and associated measurements at
lower levels to avoid undesirable effects.
Interviews with patients about their
experience
C
IF contract payments are made at the
same time to all partners and tied to PCC
and HP outcomes, THEN this fosters trust
and productivity towards aligned
outcomes [47]




Monitor payment transactions (frequency
and scheduling), organizational setting and
structures, and how these affect transaction
hazards. Interviews based on defined
transaction hazards in alliance contract
D
IF incentives are provided to all
individuals on the team (e.g., nurses,
occupational therapists, etc.) and consist
of the wider range of rewards (extrinsic
and intrinsic rewards), THEN desired
outcomes are more likely [48–50]
because everyone is on
board to provide PCC and
feels that the organization’s
goals are congruent with
their own
Patient experience questionnaires to measure
PCC (P3c-EQ, PPE15). Objective evaluation
from quality controllers. Professional and
patient focus groups
E
If “Quality measures” are linked to PCC
ideas and information systems (e.g.,
accounting system) and able to deliver
information about cost containment or
other quantitative indicators
improvement against non-EHL settings
(benchmarking), THEN the measurement
process itself will be an incentive [51]
the measurement process
has also the function of
ex-ante control applied
“Quality measures” enabler
Audit of use of quality measures and linkage
to information system. Interviews with
delivery and management staff on
acceptability and effectiveness.
Benchmarking with non-EHL settings
F
If mobile technologies (e.g., SMS
reminders, mobile symptom monitoring
etc.) are used by organizations, THEN
PCC goals and HP are supported for
self-management activities [52]
people are more receptive
and in control of their own
health
Number of interactions and activities
performed by utilizing IT. Number of reviews.
Number of follow-ups. Number of care
contact changes over time. Patient surveys
regarding experiences and outcomes
following communication episodes. (PPE15.
P3C-EQ)
F
IF IT systems are used to support
dynamic and goal-oriented electronic
health records (EHRs) that include patient
inputs, THEN EHRs and care plans can
be more PCC [53,54]
technology will enable
patients to better manage
their illness and care teams
to address the patient’s
overall needs, concerns, and
goals with a single plan
Number of created functionalities to permit
easy tracking of an individual patient over
time (e.g., prior hospitalizations). Existence
of care management software built into the
EHR. Creation of huddle sheets and pre-visit
planning tools that can be populated with
important patient data (e.g., medications,
problem list). Interviews with participants
and care team
G
IF staff training in empowerment and
communication is provided, THEN this
improves PCC [55–57]
it enables relationships with
patients as capable people,
and both parties have
greater participation in care
Number of staff trainings for PCC,
empowerment workshops and reflection
meetings. Outcomes measured by
Individualized Care Scale, Ways of Coping
Questionnaire and EQ-5D. Video recording
and coding of healthcare provider—patient
interactions
G
IF feedback is provided to patients from
staff using data from patient-reported
measures, THEN this can improve the
responsiveness of clinicians and improve
patient information and choice [58]
the patient perspective
drives the care interaction
and care plan
Sample of care plans compared with patient
reported outcome measure (PROM) data.
Interviews with staff and patients
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3.3. Design the Evaluation and Fit with Service Change
The evaluation of EHLs should address questions that will enable commissioners of health services
and delivery organizations to implement, sustain, and scale up the innovations. Key evaluation
questions for the EHLs will include those that probe PCC processes, practices, and patient experiences
of PCC care as markers of quality PCC. The health outcomes measured should be relevant to the
patient and their family, health care provider, and other decision-makers. Key areas of interest in the
implementation of PCC are changes in functional ability, experiences of care, self-efficacy, and cost.
EHLs will also be informed by Wilson and Cleary’s [68] model for integrating concepts of biomedical
outcomes and measures of health-related quality of life: (i) Biological and physiological factors, (ii)
symptoms, (iii) functional status, (iv) general health perceptions, and (v) overall quality of life). Specific
questions (see Figure 3) will also probe the mechanistic relationship between the critical enablers and





















Is “the EHL” treating people in a personalised manner? How is this defined? 
Are people involved in decisions and planning their care with their professional teams? 
Do professionals ask about an individual’s preferences (both treatment preferences and outcome 
preferences/goals)?  
Do professionals understand the person in their sociocultural context and identify their capacities and assets? 
Do professionals and people (with relatives) work in partnership?  
Does the system enable people to feel in control of their treatment and care?   
Are those individuals at low levels of self-efficacy or confidence supported to manage their health and well-
being?  
Is the test lab acceptable to citizens/patients, staff and managers? 
Is the test lab equitable?  
Does the evaluation framework include ways and means to measure:  
Social determinants, inequity and inequality 
Experience of care and support 
Impact on service utilisation? (Emergency visits, unplanned admissions etc.) 
Prevention of illness   
Employability/return to work   
Avoidance of crisis and exacerbations in conditions 
Specific medical & health outcomes relevant to intervention  
How do the critical enablers support the implementation of the innovation?   
What are the challengers and barriers within the system?  How are they addressed in the lab? 
At what organisational level are the challenges and barriers operating & what are the strategies for 
overcoming them? 
Figure 3. Questions for PCC practice and experience as a quality marker.
3.4. Economic Evaluation and Specific Questions for Cost Containment
Irrespective of the type of intervention, commissioners and policy makers require proof that
the additional health care resources needed to make the procedure, service, or program available to
those who could benefit from it are justified [71]. The purpose of economic evaluation is to inform
such funding decisions. An economic evaluation deals with both inputs and outputs (costs and
consequences) of alternative courses of action, and is concerned with choices and consideration of the
costs and benefits at multiple levels. EHLs will therefore have to evaluate the main costs involved
in the change of a healthcare system towards PCC and HP. Weinstein [72] identifies costs related to
changes in the use of healthcare resources, changes in the use of non-healthcare resources, changes in
the use of informal caregiver time, and changes in the use of patient time (for treatment). In a similar
way, Drummond et al. [71] identifies health sector costs, other sector costs, patient/family costs, and
productivity losses. Measurement within economic evaluation expands beyond the healthcare system
under study.
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According to Weinstein [72], direct health care costs include all types of resource use, including
professional, family, volunteer, or patient time, as well as the costs of tests, drugs, supplies, healthcare
personnel, and medical facilities. Non-direct health care costs include the additional costs related with
the intervention, such as those for childcare (for a parent attending a treatment), the increase of costs
required by a dietary prescription, and the costs of transportation to and from the clinic; they also
include the time family or volunteers spend providing home care. Citizen time costs include the time
a person spends seeking care or participating in or undergoing an intervention or treatment. Time
costs also include travel and waiting times as well as the time receiving treatment. Productivity costs
include (1) the costs associated with a lost or impaired ability to work or to engage in leisure activities
due to morbidity and (2) lost economic productivity due to death.
The World Health Organization (WHO) recognizes quality health care in those organizations that
have a high degree of professional excellence, with minimum risks, good health outcomes for patients,
and efficient use of resources [1,73]. To promote the health of the population, the WHO recommends
key objectives for continuous quality improvement in health care. These include the structuring of
health services, the rational and efficient use of both human and financial resources, and the guarantee
of professional competence to citizens in order to meet their needs. Measures or questions relating to



























Is the test lab efficient? How is this defined?  
How can the test lab be optimised? What needs to change? 
Does test lab link or encourage people to engage with their communities?  
What are the costs of the innovation (staff costs, infrastructure) per citizen/patient and at aggregate 
level?  
How are costs incurred or saved within the wider system (spillover effects)?  
What is the effect of the innovation on defined cost outcomes such as service utilisation (prevention of 
costly healthcare such as ED visits and unplanned admissions, length of stay etc.), self-management 
and prevention, improvements in physical health and medicines optimisation?  
Is the EHL coordinating its activities around the person and their carers/family? 
Are carers supported? 
Are community assets are being deployed, including peers, social networks, and the voluntary sector?   
Figure 4. Questions for cost in the “health labs”.
3.5. Measures and Metrics to Answer the Questions: A Core Minimum Data Set
The evaluation of the EHLs must contain the most suitable measures and approaches to answer
the questions. Quantifiable measures or questions can either be aggregated (single criterion analysis)
or handled separately (multi-criteria analysis). Careful consideration of the combination of qualitative
and quantitative approaches is advised, particularly since different health systems display different
capabilities in this regard. In terms of minimum design standards, at least two data collection
points—pre-and post-intervention/implementation—are recommended. This is the minimum standard
advised. Should the availability of knowledge, skills, and resources be forthcoming, more complex
experimental and implementation-focused designs could be undertaken upon careful consideration
of the amount of preexisting evidence for PCC in that particular context or condition [74]. Ideally,
monitoring and data collection will be continuous and with feedback to practice, with long follow-up
periods to capture lasting changes in care delivery and outcomes. To account for the variance in EHLs,
a core minimum data set from each site with three categories of data is recommended: Routinely
collected audit data or similar (e.g., collected at country or hospital level); questionnaire data specifically
collected for the EHL; and qualitative data to support implementation development. Examples of
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suitable measures, depending on the focus of the changes in the healthcare system that are implemented,
are given in Table 1. As an EHL is scaled out in practice, it may be necessary to add new measurements
to capture unanticipated and/or unintended changes.
3.6. Sampling and Timing of Data Collection
A metrics framework provides the structure for planning the sampling and timing of data
collection during the evaluation of an EHL. It is likely that data could flow from different sources,
e.g., routinely collected data and quantifiable data, surveys, and qualitative data. The PT will guide
the sampling strategies for data collection, the timing of data collection, and the various units of
analysis. Qualitative approaches will always necessitate careful sampling because they are resource
and time intensive. In contrast, an EHL may decide on a questionnaire to measure the experiences
of all those using a service to canvas a broad view. The trade-off between qualitative approaches
and more structured approaches involves considerations of depth versus breadth; different sampling
strategies are required for different forms of data.
As qualitative approaches are effective for determining “how and why” the EHL is working, it
will be important to consider a range of perspectives. Sampling should therefore aim for diversity
in terms of ethnicity, social and economic status, age, disability, and health conditions. Services may
also decide to film or record care interactions for ongoing implementation and quality improvement
activities, using purposeful samples or random selection. Convenience and pragmatism will also play
a role in any sampling procedure, which is common in applied health care research and evaluation,
where time and resources are limited.
The phasing of data collection will likely include baseline data and follow-up data to mirror
the timeframes of the intervention. It might also be necessary (providing sufficient justification and
acceptability from practitioners and patients) that focused data capture on a specific element of the
delivery is added into the core set of measures at particular times. For example, if communication or
shared decision-making was an improvement target, implementing a tool that specifically addresses
this issue of relational care could be used as both the intervention and data collection [75].
3.7. Routinely Collected Data, Linked Data Sets and Matched Cohorts
The potential to link health and social care data to understand an individual’s pathway following
exposure to an EHL will be determined by local ethical restrictions, data flow, and governance
guidelines. Linked data sets (or even unified data sets) allow for a longitudinal exploration of the
impact of the intervention on service utilization (costs) and health using time series analysis or
similar [76]. Analysis will be more powerful if compared to a control cohort (tracked by a unique
identifier following explicit consent) of people who are part of a health lab. The use of techniques, such
as propensity scoring, to identify and match control groups of service users are particularly helpful for
this type of evaluation and service development [77].
3.8. Analysis
The analysis plan should be informed by the PTs and shaped by the evaluation framework.
In principle, three main stages of analysis are envisaged. The first stage will commence with univariate
analysis to examine each variable or source of data (for example, acceptability of services as a measure
of quality or use of care plans as a measure of IT) independently. This could explore the time trends in
say routinely collected data and the statistical properties of the data, e.g., the distribution of the data.
Parallel qualitative analysis could seek to surface emerging themes. In the second stage, for each EHL,
the PT will be tested to check if it is functioning as expected. In the third stage, findings both within
and across the EHLs will be compared to answer the higher-order questions about the relationships
between the quality of care and cost containment.
Working to understand trends in the data and other potential factors influencing outcomes (i.e.,
closure of a community hospital, or lack of out-of-hours primary care) will be a necessary effort.
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Collaboration between academic and health science partners will facilitate a robust evaluation, linking
efforts to capture patient experiences and outcomes with cost indicators. The ultimate result will be a
more nuanced story of how the intervention is delivered, experienced, and the extent to which it is
achieving change. In this regard, it is important to note that change may not be immediate. Even if
change is achieved quickly, impact on outcomes may require longer-term follow-up, especially, for
instance, to demonstrate the cost-benefit ratio.
3.9. Barriers to Implementation
To convince European societies and key decision-makers at a national and an EU level that
the WE-CARE Roadmap is viable, reliable evidence from the EHLs based on robust evaluation and
implementation is required. Many barriers and uncertainties may threaten the implementation of PCC.
The first is the quality and accuracy of the PT that underpins the EHL model; whether it includes all
key aspects needed to provide PCC, if it examines quality care and/or cost, and the extent to which it
includes the enablers within the EHL. The model should also be appealing and promise significant
benefits, in order to convince key stakeholders of the potential EHL. However, not only is the quality of
the theoretical model important, the legitimacy and reliability of the person or organization presenting
the model to its future users is also crucial [78]. The engagement of authoritative local leaders who
endorse the model to a range of stakeholders will be important to achieve early on in the process.
This is likely to affect stakeholders’ perception of its quality and validity [79], as well as its advantage
over alternative solutions [80,81].
3.9.1. Enablers at Multiple Levels
The EHLs will affect people, their families, health professionals, and employees throughout the
organization, including managers. Thus, a bundle of incentives for different groups will probably be
required. Varied incentives, not only financial, as pay-for-performance, but also prospects of increased
external recognition or legitimacy for participant organizations should be considered. The title of “the
best provider”, achieved by public benchmarking, could be an example. This requires accurate outcome
measurement. Incentive bundles can apply to three enablers of WE-CARE Roadmap: Incentive systems,
quality measures, and contracting strategies.
3.9.2. Contradictory Effects
The case-mix systems that are used in many European countries to finance hospital care are
motivating providers to admit more patients, because the more patients they serve, the higher their
income. If a hospital or a hospital ward agrees to become an EHL, the issue of contradictory incentives
is likely to arise and must be overcome. For example, if, by implementation of an innovative community
care EHL, more patients are cared for in the community, then the hospital will not receive money from
the payer for those patients. The fixed costs of the hospital will remain, creating a deficit in the hospital
system. A risk-reward sharing framework between the hospital and community provider could agree
to cover hospital losses over the course of the project, but provisions for who will pay the fixed costs
afterwards would need to be considered. Involving key stakeholders from across the system will be
important to provide strategies to overcome these conflicting issues.
There should also be a distinction made between the average and the marginal cost of in-patient
care. For example, the costs of a hospital ward (e.g., general medicine) are unlikely to differ significantly
between a 10- or 20-patient occupancy. This means, that even if a treatment of a group of patients
was organized outside of a hospital and the hospital infrastructure remained unchanged, the cost
savings would be meagre or illusory. If, after introduction of the innovative care system, the medical
infrastructure seemed unnecessary, then EHL employees would need to be motivated to support the
EHL to ensure sustainability.
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3.9.3. Organizational Climate and Culture
The extent to which the organizational climate is favorable for EHL implementation must also be
considered [80]. The implementation climate is more evident and less stable than the organizational
culture and is thus more susceptible to amendments. Policies, procedures, and reward systems are
those incentives that may effectively affect the implementation climate [82]. The other fundamental
ingredient of a positive implementation climate is the extent to which important actors perceive the
current healthcare delivery model as intolerable or unsustainable and are motivated for change, defined
as cultural readiness [78]. The proposed model of the EHL should be compatible with stakeholders’
own norms and values (culture), as well as with their priorities [78,83].
To maintain a positive climate for the implementation of EHLs, important indicators related
to citizen health, well-being, quality, costs, and other important factors should be presented to
stakeholders. Thus, both the climate for change and incentives and reward systems call for accurate,
objective, and verifiable measures viable to reflect the real performance in pivotal areas. If measures
do not meet these requirements, this could undermine implementation [84]. Measures must clearly
communicate PCC goals and feedback to participants indicating the degree of goal achievement.
To support PCC implementation and address potential barriers, each PT should be linked to a
strategy with its own resources. Resources include knowledge, time, money, training, and in some
cases physical space. Especially important is the access to widely understandable and convincing
information and knowledge about PCC implementation, specifically about new work processes for
the staff and the nature of care provided to patients and their social environment. If resources are not
available, this creates a further barrier to implementation that must be effectively managed.
Organizational change begins with changes in individual behavior, although as numerous
studies have shown, this is complex and challenging [80]. Ensuring the main actors do not perceive
implementation of EHLs as threats to their own interests is a critical issue to address. Subjective
interests are, however, not often easy to identify. Powerful actors, in particular leaders who at multiple
levels across the system represent the core activity of the PCC implementation, must include physicians,
nurses, allied health and social care professionals, people, and their communities. In EHLs, leadership
should be transformational and innovative to create teams working to develop a workplace that is
person centred. This is a key factor in the delivery and sustainability of PCC [85]. If this is achieved, it
will promote cultural change and the upskilling of existing employees. Having several key people
within the organization take on this role will ensure leadership sustainability.
Although these groups should support every change to augmenting healthcare quality, such as
PCC, in reality, however, explicit or latent resistance can be a common problem [86]. The medical
and health professions are built on an ideology to protect and care for humanity over economic
profitability and self-reward [87], but contradictions between altruism and professional self-interest
have been established. The excessive self-interest of individual doctors or groups of physicians should
be mitigated by professional self-regulation and self-control [88].
3.10. Continuous Improvement
Since large-scale testing is the ultimate aim, it is assumed that a significant number of enabler
elements will be in place when an EHL begins. As suggested earlier, the EHL will be underpinned
by the PT that describes how the central work processes and independent actions of actors should
be coordinated to deliver high-quality PCC. To be effective, the model, once elaborated, will require
continuous adjustment not only to local environment factors but also to external and internal
uncertainties emerging over time in each setting. Thus, some feedback and regulatory mechanisms
should be an integral part of the model. The development and improvement of EHLs will be
facilitated by a commitment to formative learning in response to the feedback from the evaluation data
(data-driven improvement). There is a long tradition of using these methods to improve practice, and
good evidence to suggest benefit [89]. Learning will vary by organization and setting. However, it
will usually require a “plan-do-study-act” (PDSA) cycle or a similar process [90]. This will typically
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involve action learning sets [91] using quality improvement methodology [92]. Action learning sets
are particularly suited to iterative complex intervention development as they focus on learning from
interactions, thus providing a mechanism to reflect and problem solve. These skills are particularly
important for health and social care professionals who are being asked to work in a different way,
where this is likely to be challenging.
3.11. Co-Design and Participatory Action for PCC
Emancipatory research designs have been a core feature of community development and
strengths-based approaches in social care. Such approaches value the lived experience and partnership
with patients and the public in developing and evaluating services [93–96]. Research approaches based
on these principles have in the past been subject to much derision but are now becoming recognized as
critical to citizen-relevant and humanistic healthcare planning and evaluation, and align well with
the philosophy of PCC. The UK standards for patient and public involvement in the planning and
evaluation of health and social care are supported by academic, research, and government policy.
Involving patients and the public in the consultation and shaping of EHLs is a core and fundamental
standard we advocate.
4. Conclusions
This paper laid out a comprehensive plan for the evaluation of Exploratory Health Laboratories
that aims to improve the quality of health care in the EU whilst also containing costs. The plan was
developed by members of the WE-CARE FP7-funded project and COST CARES COST Action 15222
from a range of academic and professional backgrounds and different countries. This process identified
PCC and HP as the solution, along with critical enablers to facilitate implementation. Examination of
the intersections among and between these enablers, as well as the impact on quality of care and cost
of care, via evidence-based PTs provides the justification for the design and incorporation of particular
components into an EHL. Furthermore, the paper also described how these components and EHLs
might be evaluated as complex interventions at micro, meso, and macro levels. This work and the
resources it produced (www.COSTCARES.eu) are intended to serve as a reference material for those
considering setting up EHLs or similar initiatives beyond the scope of this COST Action.
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